Cepheid is cleared by the FDA to market the Xpert MRSA test, which runs on the GeneXpert System, for the rapid detection of Methicillin-resistant Staphylococcus aureus (MRSA). Xpert MRSA results, delivered in a little over one hour, identify carriers of the potential pathogen and enable healthcare organizations to implement the proper infection control measures, leading to lower hospital-acquired infection rates while improving patient care.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now